BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

GlobalData Release: Brazil's Pharmaceutical Market: Increase in Chronic and Lifestyle-Associated Diseases to Boost Sales


10/10/2013 9:55:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LONDON, UK (GlobalData), 10 October 2013 - Brazil has emerged as a manufacturing hub for pharmaceutical and biotechnology companies, with the pharma market forecast to grow from $12.4 billion in 2007 to $58.8 billion in 2020, at a Compound Annual Growth Rate (CAGR) of 12.7%, says research and consulting firm GlobalData.

The company’s latest report* states that the medical device market in Brazil will also see significant growth from $7.9 billion in 2012 to $13.1 billion by 2020, at a CAGR of 6.6%. In 2012, the main segments were ophthalmic devices ($1.5 billion), in vitro diagnostics devices ($0.9 billion), and diagnostic imaging devices ($0.8 billion).

Joshua Owide, Director of Healthcare Industry Dynamics, says: “The healthcare market in Brazil is primarily driven by an increase in disease burden, affordability, and access to primary care. However, healthcare does not cover the total population and therefore restricts further market growth.”

In fact, the Brazilian healthcare system comprises of two subsystems: public and private. The country’s private healthcare insurance system is the second largest in the world, covering approximately 23.7% of the population.

Owide says: “Brazilian hospitals still have inadequate resources and are therefore unable to provide access to healthcare provisions for every citizen, especially to those in weaker economic sections.

“However, government initiatives, such as the increased availability of generic drugs through programs including the People’s Pharmacy (Farmácia Popular), have contributed to the reduction of out-of-pocket expenditure and indirect price control, which stimulates competition from generics.”

Still, healthcare in Brazil carries the highest tax burden in comparison with other sectors of the economy, such as the education and financial system. Required taxes to the service provider can reach up to 28%, including federal and state taxes. This shows that the current tax system would require priority attention from the government, according to GlobalData.

*CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Brazil

This report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.

For guidelines on how to cite GlobalData, please see: http://www.globaldata.com/QuotingGlobalData.aspx

-ABOUT GLOBALDATA-

GlobalData is a leading global research and consulting firm offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For more information, please contact our Press Office on +44 (0)1204 543 528 or at pr@globaldata.com.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES